Format

Send to

Choose Destination
Mil Med. 2019 May 1;184(5-6):e458-e461. doi: 10.1093/milmed/usy223.

Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military.

Author information

1
School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.
2
Department of Family Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.

Abstract

Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.

KEYWORDS:

Botulinum Toxin; Chronic Exertional Compartment Syndrome; Leg Pain; Military

PMID:
30215765
DOI:
10.1093/milmed/usy223

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center